Primary germ cell tumor of central nervous system

Primary germ cell tumors of the central nervous system (CNS GCTs) are a rare group of tumors that arise from misplaced germ cells within the brain or spinal cord. These tumors most commonly occur in the pineal region and the suprasellar (above the pituitary gland) region, though they can also develop in other midline locations such as the basal ganglia or thalamus. CNS germ cell tumors encompass several histological subtypes, including germinomas (the most common and most treatment-responsive subtype) and non-germinomatous germ cell tumors (NGGCTs), which include embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma (mature and immature), and mixed germ cell tumors. These tumors predominantly affect children, adolescents, and young adults, with a notable male predominance. Symptoms depend on tumor location and size. Pineal region tumors frequently cause obstructive hydrocephalus, leading to headaches, nausea, vomiting, and Parinaud syndrome (difficulty with upward gaze). Suprasellar tumors often present with diabetes insipidus, visual field deficits, growth hormone deficiency, and other endocrine abnormalities due to disruption of the hypothalamic-pituitary axis. Some patients may experience precocious puberty, particularly with tumors that secrete human chorionic gonadotropin (hCG). Diagnosis typically involves neuroimaging (MRI), measurement of serum and cerebrospinal fluid tumor markers (alpha-fetoprotein and beta-hCG), and often histological confirmation through biopsy. Treatment varies by subtype. Pure germinomas are highly sensitive to both chemotherapy and radiation therapy, with cure rates exceeding 90% using combined modality approaches. Non-germinomatous germ cell tumors generally require more intensive platinum-based chemotherapy regimens followed by radiation therapy, and may also require surgical resection. Despite favorable outcomes for germinomas, long-term survivors may experience neurocognitive effects, endocrine deficiencies requiring lifelong hormone replacement, and other late effects of treatment. Ongoing research aims to refine treatment strategies to maximize cure rates while minimizing long-term toxicity.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Primary germ cell tumor of central nervous system